Neomycin,sulfate (salt),mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide monohydrochloride and 8-quinolinol sulfate (2:1) (salt) (57866-40-7)

Other Product

• Oleandomycin,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide,neomycin sulfate (salt) and (11â)-11,17,21-trihydroxypregna-1,4- diene-3,20-dione
• Oleandomycin,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide,neomycin sulfate (salt) and (11â)-11,17,21-trihydroxypregna-1,4- diene-3,20-dione
• Neomycin,sulfate (salt),mixt. with (4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,- 4a,5,5a,6,11,12a-octahydro-3,6,10,12,12apentahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide monohydrochloride and 3-[[(5-nitro-2-furanyl)methylene]amino]-2- oxazolidinone
• Sulfuric acid copper(2+) salt (1:1),compounds,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide
• 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,calcium salt (1:1), (4S,4aR,5S,5aR,6S,12aS)-
• 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,calcium salt (2:1), (4S,4aR,5S,5aR,6S,12aS)-
• 2-Naphthacenecarboxamide,4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-,(4S,4aR,- 5S,5aR,6S,12aS)-,mixt. with 2-methyl-5-nitro-1H-imidazole-1-ethanol and 3-[[(5-nitro-2-furanyl)methylene]amino]- 2-oxazolidinone
• Estra-1,3,5(10)-triene-3,17-diol (17â)-,esters,3-benzoate,mixt. with 2-(diethylamino)-N-(2,6-dimethylphenyl)- acetamide monohydrochloride and (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide monohydrochloride
• 2-Naphthacenecarboxamide,4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-,monohydrochloride,(4S,4aR,5S,5aR,6S,12aS)-,mixt. with (1R,2R)-2,2-dichloro-N-[2- hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)- ethyl]acetamide
• 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,calcium salt (1:2), (4S,4aR,5S,5aR,6R,12aS)-
• L-Ascorbic acid,compounds,mixt. with 3-[(4-amino-2-methyl-5-pyrimidinyl)- methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride,(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide and riboflavin
• 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-,hydrate (1:2), (4S,4aR,5S,5aR,6S,12aS)-
• Arsonic acid,(4-aminophenyl)-,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide and 3-[[(5-nitro-2-furanyl)methylene]amino]-2- oxazolidinone
• Erythromycin,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide
• 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,(4S,4aR,5S,5aR,6S,12aS)-
• 2-Naphthacenecarboxamide,4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12apentahydroxy- 6-methyl-1,11-dioxo-,monohydrochloride,(4S,4aR,5S,5aR,6R,12aS)-
• 2-Naphthacenecarboxamide,4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12apentahydroxy- 6-methyl-1,11-dioxo-,monohydrochloride,(4S,4aR,5S,5aR,6R,12aS)-
• (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,3,12(2H,4H,5H)-trione sulfate (2:1) (salt)
• 2-Naphthacenecarboxamide,4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-,monohydrochloride,(4S,4aR,5S,5aR,6S,12aS)-,mixt. with 2-amino-3,5-dibromo-N-cyclohexyl- N-methylbenzenemethanamine monohydrochloride
• 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrate (1:1), (4S,4aR,5S,5aR,6R,12aS)-